A novel RET proto-oncogene mutation in multiple endocrine neoplasia type 2A
10.3760/cma.j.issn.1000-6699.2013.06.013
- VernacularTitle:多发性内分泌腺瘤病2A型RET原癌基因新的突变方式
- Author:
Mengmeng CAO
;
Liangge SUN
;
Yali ZHU
;
Lei REN
;
Mengyang ZHANG
;
Xiaoya ZHANG
- Publication Type:Journal Article
- Keywords:
Multiple endocrine neoplasia type 2A;
Missense mutation;
RET proto-oncogene
- From:
Chinese Journal of Endocrinology and Metabolism
2013;(6):498-503
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the mode of RET proto-oncogene mutation in a pedigree with multiple endocrine neoplasia type 2A (MEN2A).Methods Six members from a MEN2A family,including the proband,were enrolled.Genomic DNAs of these members were extracted from peripheral blood lymphocytes for polymerase chain reaction(PCR),PCR products of 21 exons of the RET proto-oncogene were purified and a direct gene sequence analysis was performed.DNA sequencing was performed on the related exon of the other family members after verifying the mutation site.Results The female proband sufferd from pheochromocytoma and medullary thyroid carcinoma since the age of 45,two missense mutations of TGC(Cys) to TCC(Ser) at codon 634 and CTG(Leu) to TTT(Phe) at codon 633 in exon 11 of the RET proto-oncogene were detected in the proband,while the other members remain unchanged.Conclusions Analysis of the RET proto-oncogene identifies a united mutation of TGC (Cys) to TCC (Ser) at codon 634 and CTG(Leu) to TTT(Phe) at codon 633 in the proband.The former is a proven mutation related to MEN2A,while the latter has never been reported before.
